
ADLM Diagnostics Innovation and COVID Testing
In this Bio Break episode, Nick Allan and Nigel Syrotuck reflect on recent ADLM diagnostics innovation and how it has shaped the future of clinical testing. The Association for Diagnostics & Laboratory Medicine (ADLM) recently wrapped its annual showcase in Chicago, and as always, it left a strong impression on the medtech community.
While discussing highlights from the show, Nick and Nigel zero in on a perfect case study of ADLM diagnostics innovation: the evolution of COVID-19 testing. From the early days of enzyme-linked immunosorbent assays (ELISAs) to the familiar lateral flow tests we now perform at home, diagnostics have become faster, simpler, and more accessible. This transformation—from complex lab environments to point-of-care and even bathroom-counter diagnostics—was on full display at ADLM.
From the Lab to the Bathroom Counter
As Nick points out, one of the most remarkable shifts in diagnostics is how complicated procedures have been distilled into everyday routines. What once required trained technicians in controlled environments can now be done at home, often with little more than a test strip and a timer. The lateral flow transformation is a clear example of how ADLM’s influence and technology leadership help shape the direction of consumer-friendly diagnostics.
Related Resources

Jason McGee explores how the Rightness Trap Medtech dynamic can quietly erode enterprise value in medical device companies.

Understanding gram positive vs negative bacteria is essential when studying sterility, microbiology, and antibiotic effectiveness. While many people think the difference is only about staining, the reality is much deeper.

Nick and Nigel explore the science behind hand sanitizer formulations. They discuss how alcohol interacts with bacterial cells, why water improves its effectiveness, and what the additional ingredients in sanitizer actually do.

Scott Phillips, CEO of StarFish Medical, sits down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic thinking behind major MedTech transactions and investments.